Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

8 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

Phase 4

6(60.0%)

N/A

2(20.0%)

Phase 3

2(20.0%)

10Total

Phase 4(6)

N/A(2)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT04983173Phase 4Completed

INTEnsity of ovariaN Stimulation and Embryo Quality

Role: lead

NCT04719000Phase 4Recruiting

PErsonalized Addition of Recombinant LH in Ovarian Stimulation

Role: lead

NCT05899010Phase 3Recruiting

MIcronized PROgesterone in Frozen Embryo Transfer Cycles

Role: lead

NCT06134479Phase 3Completed

Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.

Role: lead

NCT04880590Recruiting

Sex or no Sex: That is the Question.

Role: lead

NCT06154083Phase 4Recruiting

INtensity of OVarian Stimualtion and Euploid Embryos

Role: lead

NCT06635538Not ApplicableRecruiting

One-shot Ovarian Stimulation Protocol (One-shot)

Role: lead

NCT06425978Phase 4Recruiting

Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit

Role: lead

NCT04821492Completed

Relationship Between Homocysteine and BMD

Role: lead

NCT04992468Phase 4Completed

Dual Trigger for Elective Fertility Preservation

Role: lead

NCT04446845Phase 4Completed

Double Stimulation Followed by a Fresh Embryo Transfer

Role: lead

NCT03740568Not ApplicableCompleted

Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes.

Role: collaborator

All 12 trials loaded